| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), RLMD's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.30M | $5.81M | - | |
| COO | 828.0K | $3.70M | - | |
| Other | 828.0K | $3.70M | - | |
| CFO | 800.0K | $3.58M | - | |
| Dir | 164.0K | $733.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2015 | Traversa Sergio64 | Chief Executive Officer | Buy | 30 | $2.97 | $89.10 | - | |
| Dec 14, 2015 | Kelly Paul Edward67 | Director | Buy | 10,000 | $2.91 | $29,055.00 | +33.4% |